Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$1,239,000
in 1 filing
Open-market sales, last 90 days
$1,708,041
in 8 filings, $650K under 10b5-1 plans

Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-29 DOYLE THOMAS JAMES SVP, Finance & Accounting Sale −594 $17.80 $11K 49,817
2024-01-29 DOYLE THOMAS JAMES SVP, Finance & Accounting Sale −761 $17.80 $14K 49,056
2024-01-29 DOYLE THOMAS JAMES SVP, Finance & Accounting Sale −963 $17.80 $17K 48,093
2024-01-29 Bair Teresa Brophy Chief Legal Officer Sale −2,053 $17.80 $37K 68,979
2024-01-29 FORD KATHLEEN Chief Operating Officer Sale −1,496 $17.80 $27K 21,602
2024-01-29 DALE STEPHEN Chief Medical Officer Sale −4,400 $17.80 $78K 46,400
2024-01-29 DALE STEPHEN Chief Medical Officer Sale −2,758 $17.80 $49K 43,642
2024-01-24 WILSON TROY EDWARD President and CEO Option exercise +6,945 $4.80 $33K 7,504
2024-01-24 WILSON TROY EDWARD President and CEO Sale −6,945 $20.23 $140K 559
2024-01-24 WILSON TROY EDWARD President and CEO Option exercise +84,107 $6.15 $517K 84,666
2024-01-24 WILSON TROY EDWARD President and CEO Sale −84,107 $20.23 $1.7M 559
2024-01-02 DOYLE THOMAS JAMES SVP, Finance & Accounting Grant or award +21,250 50,411
2024-01-02 DOYLE THOMAS JAMES SVP, Finance & Accounting Grant or award · Option to purchase common stock +42,500 42,500
2024-01-02 Powl Brian T. Chief Commercial Officer Grant or award +15,000 15,000
2024-01-02 Powl Brian T. Chief Commercial Officer Grant or award · Option to purchase common stock +30,000 30,000
2024-01-02 Bair Teresa Brophy Chief Legal Officer Grant or award +46,250 71,032
2024-01-02 Bair Teresa Brophy Chief Legal Officer Grant or award · Option to purchase common stock +92,500 92,500
2024-01-02 FORD KATHLEEN Chief Operating Officer Grant or award · Option to purchase common stock +185,000 185,000
2024-01-02 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +185,000 185,000
2024-01-02 WILSON TROY EDWARD President and CEO Grant or award · Option to purchase common stock +560,000 560,000

Page 8 of 9 · 164 trades